Abstract: A method and composition for accelerating the healing of wounds in animals and humans is disclosed. The method comprises administration of ascorbic acid, a source of biologically available calcium, a precursor or stimulant of epinephrine or nor-epinephrine selected from tyrosine and phenylalanine, and an anti-inflammatory substance selected from anti-inflammatory sugars, amino sugars and biocompatible acid addition salts thereof, and anti-inflammatory amino acids. Treatment in accordance with the present method reduces or prevents tissue degenerative effects of the inflammation associated with the natural wound healing process and promotes connective tissue (scar tissue) growth in the wound.
Abstract: A method and composition for treatment of tissue degenerative inflammatory disease in animals and humans afflicted with such disease or disposed to development thereof is disclosed. The method comprises oral administration of ascorbic acid, a source of biologically available calcium, a precursor or stimulant of epinephrine or nor-epinephrine selected from tyrosine and phenylalanine, and an anti-inflammatory substance selected from anti-inflammatory sugars, amino sugars and biocompatible acid addition salts thereof, and anti-inflammatory amino acids. Treatment in accordance with the present method reduces or prevents tissue degenerative effects of the inflammatory disease and promotes connective tissue regrowth.
Abstract: A composition for preventing and treating periodontal disease, comprising bone meal, ascorbic acid, tyrosine, and either glucosamine or cysteine.